Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Courtioux

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-<i>a</i>]pyridine Antileishmanial PharmacophoreRomain Paoli-Lombardo, Nicolas Primas, Sandra Bourgeade-Delmas, et al.
Chemical Biology & Drug Design|December 22, 2017
Design, synthesis, and antiprotozoal evaluation of new 2,9-bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline derivativesJean Guillon, Anita Cohen, Rabindra Nath Das, et al.
European Journal of Medicinal Chemistry|June 10, 2018
Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR studyJulien Pedron, Clotilde Boudot, Sébastien Hutter, et al.
European Journal of Medicinal Chemistry|August 10, 2018
8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductasesCyril Fersing, Clotilde Boudot, Julien Pedron, et al.
Pathogens (Basel, Switzerland)|November 24, 2022
Design, Synthesis, and Antiprotozoal Evaluation of New Promising 2,9-<i>Bis</i>[(substituted-aminomethyl)]-4,7-phenyl-1,10-phenanthroline Derivatives, a Potential Alternative Scaffold to Drug EffluxJean Guillon, Anita Cohen, Clotilde Boudot, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 5, 2020
Design, synthesis, and antiprotozoal evaluation of new 2,4-bis[(substituted-aminomethyl)phenyl]quinoline, 1,3-bis[(substituted-aminomethyl)phenyl]isoquinoline and 2,4-bis[(substituted-aminomethyl)phenyl]quinazoline derivativesJean Guillon, Anita Cohen, Clotilde Boudot, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
New 8-Nitroquinolinone Derivative Displaying Submicromolar <i>in Vitro</i> Activities against Both <i>Trypanosoma brucei</i> and <i>cruzi</i>Julien Pedron, Clotilde Boudot, Jean-Yves Brossas, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Nongenotoxic 3-Nitroimidazo[1,2-<i>a</i>]pyridines Are NTR1 Substrates That Display Potent <i>in Vitro</i> Antileishmanial ActivityCyril Fersing, Louise Basmaciyan, Clotilde Boudot, et al.
European Journal of Medicinal Chemistry|August 16, 2020
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic propertiesCyril Fersing, Clotilde Boudot, Romain Paoli-Lombardo, et al.
European Journal of Medicinal Chemistry|July 12, 2020
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruziCyril Fersing, Clotilde Boudot, Caroline Castera-Ducros, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-<i>a</i>]pyridine Antileishmanial PharmacophoreRomain Paoli-Lombardo, Nicolas Primas, Sandra Bourgeade-Delmas, et al.
Chemical Biology & Drug Design|December 22, 2017
Design, synthesis, and antiprotozoal evaluation of new 2,9-bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline derivativesJean Guillon, Anita Cohen, Rabindra Nath Das, et al.
European Journal of Medicinal Chemistry|June 10, 2018
Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR studyJulien Pedron, Clotilde Boudot, Sébastien Hutter, et al.
European Journal of Medicinal Chemistry|August 10, 2018
8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductasesCyril Fersing, Clotilde Boudot, Julien Pedron, et al.
Pathogens (Basel, Switzerland)|November 24, 2022
Design, Synthesis, and Antiprotozoal Evaluation of New Promising 2,9-<i>Bis</i>[(substituted-aminomethyl)]-4,7-phenyl-1,10-phenanthroline Derivatives, a Potential Alternative Scaffold to Drug EffluxJean Guillon, Anita Cohen, Clotilde Boudot, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 5, 2020
Design, synthesis, and antiprotozoal evaluation of new 2,4-bis[(substituted-aminomethyl)phenyl]quinoline, 1,3-bis[(substituted-aminomethyl)phenyl]isoquinoline and 2,4-bis[(substituted-aminomethyl)phenyl]quinazoline derivativesJean Guillon, Anita Cohen, Clotilde Boudot, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
New 8-Nitroquinolinone Derivative Displaying Submicromolar <i>in Vitro</i> Activities against Both <i>Trypanosoma brucei</i> and <i>cruzi</i>Julien Pedron, Clotilde Boudot, Jean-Yves Brossas, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Nongenotoxic 3-Nitroimidazo[1,2-<i>a</i>]pyridines Are NTR1 Substrates That Display Potent <i>in Vitro</i> Antileishmanial ActivityCyril Fersing, Louise Basmaciyan, Clotilde Boudot, et al.
European Journal of Medicinal Chemistry|August 16, 2020
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic propertiesCyril Fersing, Clotilde Boudot, Romain Paoli-Lombardo, et al.
European Journal of Medicinal Chemistry|July 12, 2020
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruziCyril Fersing, Clotilde Boudot, Caroline Castera-Ducros, et al.
Pageof 4